Barcelona Science Park announces a new artistic intervention contest to decorate an outdoor space Blog Post

Barcelona Science Park (PCB) announces a new artistic intervention contest to promote the interaction between art and science. The public and anonymous event offers the opportunity to create, with total thematic freedom, a mural in an outdoor space of 4.5 metres of height per 6.5 metres of width in the Clúster II building, in a junction of various areas of the park at different levels.

 

Baula donates 18,000 cleaning kits to Càritas Girona Blog Post

The startup Baula, based in the Barcelona Science Park, has donated 18,000 kits of ecological cleaning products to Cáritas Diocesana de Girona, which will be distributed as basic necessities to vulnerable families cared for by the entity. The capsule format facilitates transportation and logistics compared to conventional products. The provision of goods to 18,000 families would equate to 72,000 kilograms of conventional cleaning products. In comparison, Baula’s tablets weigh a total of 4,500 kilograms.

 

Esteve adds its weight to the fight against the pandemic through donations and research collaborations Blog Post

Esteve is participating in 3 European projects aimed at identifying and/or repositioning drugs that are active against COVID-19; at detecting SARS-CoV-2 ; and at analyzing the involvement of the sigma-1 receptor in the viral infection cycle. Additionally, the pharmaceutical group –which has its Drug Discovery and Preclinical Development Center at the Barcelona Science Park– has made donations targeted at health professionals, patients and people on the frontline of the COVID-19 pandemic.

 

Bioengineering contributes to new advances against childhood cancer Blog Post

Researchers from the Institute for Bioengineering of Catalonia (IBEC) at the Barcelona Science Park, the INCLIVA Health Research Institute and the Hospital Clínico de Valencia have discovered how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. The study, published in Scientific Reports, opens the door to generate more accurate models to predict tumor development in patients and to work in the design of new treatments.

 

Avinent collaborates with Althaia and other institutions to produce PPE with 3D printing technology Blog Post

The company Avinent, present in the Barcelona Science Park, is doing a collaborative project with Althaia Foundation, Bages University Foundation (FUB-UManresa), Eurecat, the Universitat Politécnica de Cataluña (UPC) and Manresa City Council to produce Personal Protective Equipment (PPE) with 3D printing technology. This alliance is concreted with the fabrication of face protection screens and door handles to open with the forearm.

 

Barcelona Science Park launches photo contest at Instagram “Un dia al PCB… i a casa!” Blog Post

Barcelona Science Park (PCB) presents “Un dia al PCB… i a casa!” (One day at PCB and at home), a special edition of its traditional photo contest “Un dia al PCB”, now adapted to the new situation provoked by the SARS-Cov-2 pandemic. As every year, the contest invites our community to present pictures of people, places and situations related to the Park but, this time now, also pictures of work life at home, that has become our temporary workplace.

 

Histones and their modifications are crucial for adaptation to cell stress Blog Post

The Cell Signaling laboratory at IRB Barcelona, ​​led by Eulàlia de Nadal and Francesc Posas at the Barcelona Science Park, has identified more than 200 regions (amino acids) in histones that are responsible for regulating the response to cell stress. The study reports that histones undergo distinct modifications depending on the type of cell stress.

 

SOM Biotech announces the in vitro confirmation of three drug candidates for COVID-19 with the Ewha Womans University Blog Post

SOM Biotech, a clinical-stage drug discovery and development company based in the Barcelona Science Park, announces the in vitro validation of three drug candidates as new therapies for the treatment of COVID-19 in collaboration with the Ewha Womans University in South Korea. A patent application has been filed to provide method of use protection for the three compounds worldwide. All three drugs can be repurposed to treat COVID-19 and the company is working on the fastest way to prove them in patients.